Skip to the page

Data / Form D filings / Entheos Labs, Inc.

Entheos Labs, Inc.: Form D filing

Entheos Labs, Inc., a health care company in Brookline, MA, filed a Form D with the SEC in 2024. The latest, on October 10, 2024, reports $3.6 million sold of a $10 million offering to 26 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1600 BEACON ST, Brookline, MA, 02446
Phone
(617) 651-3442
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2040837

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 10, 2024New notice$10,000,000$3,579,985$6,420,01526Sep 25, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Lawrence Tristan GozlanDirector
Brian Tristan MaloneExecutive Officer
Alexander Tristan EdwardsExecutive Officer, Director
Jerrold Tristan RosenbaumDirector
James Tristan WilkinsonDirector

Other health care companies in Massachusetts that filed recently

Every Form D from the week of Oct 7, 2024 · All recent filings in Massachusetts · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Entheos Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.